Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by SurfForWealthon Apr 01, 2004 10:48am
151 Views
Post# 7299287

What's up?

What's up?I am really getting tired of CEO's that publically set expectations with investors only to fall well short. Are we to not believe anything they say? If we cannot believe them then how do we put any type of valuation on the stocks? BS we were told No. 1 From the Robtv interview last November, CEO Desy told us that they will be profitable from that point forward because of the Gen-Probe deal. They lost 1 cent...that is not profitable! BS we were told No. 2 From same interview we were told the expenses for FY2004 would be around $250K per month which amounts to $750K per Q. They were actually double that! BS we were told No. 3 From same interview we were told to expect product revenue of around $3-3.5M for FY2004. Well in Q1 we got $200K. Now I realize that they expect revenue to ramp higher as the FY progresses but it seems like they have a near impossible target based on Q1 results. Can anyone explain these lies to me? While I see huge potential for this company, I am very annoyed by such significant descrepancies from what we were told and what I did my analysis on before I bought into the story. Cheers!!!
Bullboard Posts